List was last updated on
.-
- Prophylactic Radical Fimbriectomy with Delayed Oophorectomy in Women with a High Risk of Developing an Ovarian Carcinoma: Results of a Prospective National Pilot Study.
- Leblanc E, Narducci F, Ferron G, Mailliez A, Charvolin JY, El Hajj H, Guyon F, Fourchotte V, Lambaudie E, Crouzet A, Fouche Y, Gouy S, Collinet P, Caquant F, Pomel C, Golfier F, Vaini-Cowen V, Fournier I, Salzet M, Tresch E, Probst A, Lemaire AS, Le Deley MC, Hudry D.
- Cancers (Basel). 2023 Feb 10;15(4):1141. doi: 10.3390/cancers15041141.
•• Identifier: NCT01608074: Radical Fimbriectomy for Young BRCA Mutation Carriers (Fimbriectomy). (ClinicalTrials.gov . Accessed 2023 Feb 12.)
-
- Uptake and Effectiveness of Risk-Reducing Surgeries in Unaffected Female BRCA1 and BRCA2 Carriers: A Single Institution Experience in the Czech Republic.
- Zimovjanova M, Bielcikova Z, Miskovicova M, Vocka M, Zimovjanova A, Marian Rybar M, Novotny J, Petruzelka L.
- Cancers (Basel). 2023 Feb 8;15(4):1072. doi: 10.3390/cancers15041072.
-
- Effectiveness of Secondary Risk-Reducing Strategies in Patients With Unilateral Breast Cancer With Pathogenic Variants of BRCA1 and BRCA2 Subjected to Breast-Conserving Surgery: Evidence-Based Simulation Study.
- Maksimenko J, Rodrigues PP, Nakazawa-Miklaševiča M, Pinto D, Miklaševičs E, Trofimovičs G, Gardovskis J, Cardoso F, Cardoso MJ.
- JMIR Form Res. 2022 Dec 29;6(12):e37144. doi: 10.2196/37144.
- PMID: 36580360
- PubMed abstract
-
- The risks of cancer in older women with BRCA pathogenic variants: How far have we come?
- Metcalfe KA, Gronwald J, Tung NM, McCuaig JM, Eisen A, Elser C, Foulkes WD, Neuhausen SL, Senter L, Moller P, Bordeleau L, Fruscio R, Velsher L, Zakalik D, Olopade OI, Eng C, Pal T, Cullinane CA, Couch FJ, Kotsopoulos J, Sun P, Lubinski J, Narod SA.
- Cancer. 2022 Dec 26. doi: 10.1002/cncr.34615. Epub ahead of print.
- PMID: 36571512
- PubMed abstract
- Source abstract
-
- Considerations for the Risk of Peritoneal Carcinomatosis After Risk-Reducing Salpingo-Oophorectomy.
- Zhang J, Liu M.
- J Clin Oncol. 2022 Nov 10;40(32):3783. doi: 10.1200/JCO.22.00726. Epub 2022 Jul 12.
- PMID: 35820079
- PubMed abstract
- Letter, Commentary
- Free Full Text
•• Original research:
Risk of Peritoneal Carcinomatosis After Risk-Reducing Salpingo-Oophorectomy: A Systematic Review and Individual Patient Data Meta-Analysis.
- PMID: 35302882
- PubMed abstract
- Source abstract
•• Reply, Letter:
Reply to J. Zhang et al.
- PMID: 35820084
- PubMed abstract
- Free Full Text
-
- Outcome and management of STIC following opportunistic salpingectomy: systematic review and meta-analysis.
- Ruel-Laliberté J, Kasasni SM, Oprea D, Viau M.
- J Obstet Gynaecol Can. 2022 Sep 10:S1701-2163(22)00612-0. doi: 10.1016/j.jogc.2022.08.018. Epub ahead of print.
- PMID: 36099965
- PubMed abstract
- Source abstract
-
- Incidence of pelvic high-grade serous carcinoma after isolated STIC diagnosis: A systematic review of the literature.
- Linz VC, Löwe A, van der Ven J, Hasenburg A, Battista MJ.
- Front Oncol. 2022 Aug 31;12:951292. doi: 10.3389/fonc.2022.951292.
- PMID: 36119503
- PubMed abstract
- Review
- Free PMC article
- Free Full Text
-
- Surgical management of BRCA-mutation carriers: A single institution experience.
- Gentile D, Losurdo A, Sagona A, Zuradelli M, Gatzemeier W, Barbieri E, Testori A, Errico V, Bianchi P, Biondi E, Torrisi R, Santoro A, Tinterri C.
- Eur J Surg Oncol. 2022 Aug;48(8):1706-1712. doi: 10.1016/j.ejso.2022.04.024. Epub 2022 Apr 30.
- PMID: 35534308
- PubMed abstract
- Source abstract
-
- Risk reducing surgery with peritoneal staging in BRCA1-2 mutation carriers. A prospective study.
- Marchetti C, Arcieri M, Vertechy L, Ergasti R, Russo G, Zannoni GF, Minucci A, Ercoli A, Scambia G, Fagotti A.
- Eur J Surg Oncol. 2022 Jul 19:S0748-7983(22)00549-2. doi: 10.1016/j.ejso.2022.07.007. Epub ahead of print.
- PMID: 35871032
- PubMed abstract
- Source abstract
-
- Bilateral Oophorectomy and the Risk of Breast Cancer in BRCA1 Mutation Carriers: A Reappraisal.
- Kotsopoulos J, Lubinski J, Gronwald J, Menkiszak J, McCuaig J, Metcalfe K, Foulkes WD, Neuhausen SL, Sun S, Karlan BY, Eisen A, Tung N, Olopade OI, Couch FJ, Huzarski T, Senter L, Bordeleau L, Singer CF, Eng C, Fruscio R, Pal T, Sun P, Narod SA.
- Cancer Epidemiol Biomarkers Prev. 2022 Jul 1;31(7):1351-1358. doi: 10.1158/1055-9965.EPI-21-1196.
- PMID: 35477169
- PubMed abstract
- Source abstract
-
- The impact of oophorectomy on survival from breast cancer in patients with CHEK2 mutations.
- Tomiczek-Szwiec J, Szwiec M, Falco M, Cybulski C, Wokolorczyk D, Jakubowska A, Gronwald J, Stawicka M, Godlewski D, Kilar E, Marczyk E, Siolek M, Wisniowski R, Haus O, Sibilski R, Bodnar L, Sun P, Narod SA, Lubinski J, Huzarski T; Polish Breast Cancer Consortium.
- Br J Cancer. 2022 Jul;127(1):84-91. doi: 10.1038/s41416-022-01770-1. Epub 2022 Mar 7.
- PMID: 35256754
- PubMed abstract
- Source abstract
-
- Risk of Peritoneal Carcinomatosis After Risk-Reducing Salpingo-Oophorectomy: A Systematic Review and Individual Patient Data Meta-Analysis.
- Steenbeek MP, van Bommel MHD, Bulten J, Hulsmann JA, Bogaerts J, Garcia C, Cun HT, Lu KH, van Beekhuizen HJ, Minig L, Gaarenstroom KN, Nobbenhuis M, Krajc M, Rudaitis V, Norquist BM, Swisher EM, Mourits MJE, Massuger LFAG, Hoogerbrugge N, Hermens RPMG, IntHout J, de Hullu JA.
- J Clin Oncol. 2022 Jun 10;40(17):1879-1891. doi: 10.1200/JCO.21.02016. Epub 2022 Mar 18.
- PMID: 35302882
- PubMed abstract
- Source abstract
•• Commentary:
Risk of Peritoneal Cancer After Risk-Reducing Bilateral Salpingo-Oophorectomy for Women With Germline BRCA Pathogenic Variants: A Cause for Concern or Potentially Avoidable?
- PMID: 35333598
- PubMed abstract
- Free Full Text
•• Letter, Commentary:
Considerations for the Risk of Peritoneal Carcinomatosis After Risk-Reducing Salpingo-Oophorectomy.
- PMID: 35820079
- PubMed abstract
- Free Full Text
•• Reply, Letter:
Reply to J. Zhang et al.
- PMID: 35820084
- PubMed abstract
- Free Full Text
-
- Familial risk of epithelial ovarian cancer after accounting for gynaecological surgery: a population-based study.
- Barnard ME, Meeks H, Jarboe EA, Albro J, Camp NJ, Doherty JA.
- J Med Genet. 2022 May 9:jmedgenet-2021-108402. doi: 10.1136/jmedgenet-2021-108402. Epub ahead of print.
- PMID: 35534206
- PubMed abstract
-
- Oral Contraceptive Use in BRCA1 and BRCA2 Mutation Carriers: Absolute Cancer Risks and Benefits.
- Schrijver LH, Mooij TM, Pijpe A, Sonke GS, Mourits MJE, Andrieu N, Antoniou AC, Easton DF, Engel C, Goldgar D, John EM, Kast K, Milne RL, Olsson H, Phillips KA, Terry MB, Hopper JL, van Leeuwen FE, Rookus MA.
- J Natl Cancer Inst. 2022 Apr 11;114(4):540-552. doi: 10.1093/jnci/djac004.
- PMID: 35048954
- PubMed abstract
Commentary:
Oral Contraceptives and BRCA Cancer: A Balancing Act.
- PMID: 35048983
- PubMed abstract
- Free Full Text
-
- Earlier decisions on breast and ovarian surgery reduce cancer in women at high risk.
- Saul H, Gursul D, Cassidy S, Evans G.
- BMJ. 2022 Feb 15;376:o258. doi: 10.1136/bmj.o258.
- PMID: 35168943
- PubMed abstract
- Source abstract
Original research:
Uptake and efficacy of bilateral risk reducing surgery in unaffected female BRCA1 and BRCA2 carriers.
- PMID: 33568438
- PubMed abstract
- Source abstract
-
- Hereditary Ovarian Carcinoma: Cancer Pathogenesis Looking beyond BRCA1 and BRCA2.
- Samuel D, Diaz-Barbe A, Pinto A, Schlumbrecht M, George S.
- Cells. 2022 Feb 4;11(3):539. doi: 10.3390/cells11030539.
- PMID: 35159349
- PubMed abstract
- Source abstract
- Review
- Free Full Text
-
- Uptake and efficacy of bilateral risk reducing surgery in unaffected female BRCA1 and BRCA2 carriers.
- Marcinkute R, Woodward ER, Gandhi A, Howell S, Crosbie EJ, Wissely J, Harvey J, Highton L, Murphy J, Holland C, Edmondson R, Clayton R, Barr L, Harkness EF, Howell A, Lalloo F, Evans DG.
- J Med Genet. 2022 Feb;59(2):133-140. doi: 10.1136/jmedgenet-2020-107356. Epub 2021 Feb 10.
- PMID: 33568438
- PubMed abstract
- Source abstract
Research news:
Earlier decisions on breast and ovarian surgery reduce cancer in women at high risk.
- PMID: 35168943
- PubMed abstract
- Source abstract
-
- Long-term tumour dormancy in a BRCA1 heterozygote.
- Amuzu S, Fu L, Demko N, Rivera B, Domecq C, de Kock L, Hamel N, Gilbert L, Polak P, Ragoussis J, Foulkes WD.
- J Med Genet. 2022 Jan 17:jmedgenet-2021-108269. doi: 10.1136/jmedgenet-2021-108269. Epub ahead of print.
- PMID: 35039446
- PubMed abstract
- Source abstract
-
- Efficacy of risk-reducing salpingo-oophorectomy in BRCA1-2 variants and clinical outcomes of follow-up in patients with isolated serous tubal intraepithelial carcinoma (STIC).
- Saccardi C, Zovato S, Spagnol G, Bonaldo G, Marchetti M, Alessandrini L, Tognazzo S, Guerriero A, Vitagliano A, Laganà AS, Noventa M.
- Gynecol Oncol. 2021 Nov;163(2):364-370. doi: 10.1016/j.ygyno.2021.08.021. Epub 2021 Aug 28.
- PMID: 34465478
- PubMed abstract
- Source abstract
-
- Surgical Management of Hereditary Breast Cancer.
- Berger ER, Golshan M.
- Genes (Basel). 2021 Aug 31;12(9):1371. doi: 10.3390/genes12091371.
- PMID: 34573353
- PubMed abstract
- Source abstract
- Review
- Free PMC article
- Free Full Text
-
- Clinical and pathological outcomes of risk-reducing salpingo-oophorectomy for Japanese women with hereditary breast and ovarian cancer.
- Nomura H, Ikki A, Fusegi A, Omi M, Aoki Y, Netsu S, Tanigawa T, Matoda M, Okamoto S, Omatsu K, Nakajima T, Ueki A, Tonooka A, Kanao H.
- Int J Clin Oncol. 2021 Aug 28. doi: 10.1007/s10147-021-02020-9. Epub ahead of print.
- PMID: 34453642
- PubMed abstract
- Source abstract
-
- Bilateral salpingo-oophorectomy and breast cancer risk for BRCA1 and BRCA2 mutation carriers: Assessing the evidence.
- Conduit C, Milne RL, Friedlander ML, Phillips KA.
- Cancer Prev Res (Phila). 2021 Aug 4:canprevres.0141.2021. doi: 10.1158/1940-6207.CAPR-21-0141. Epub ahead of print.
- PMID: 34348913
- PubMed abstract
- Source abstract
- Review
- Free Full Text
-
- Risk-reducing salpingo-oophorectomy and breast cancer incidence among Jewish BRCA1/BRCA2-mutation carriers - an Israeli matched pair study.
- Perri T, Levin G, Naor-Revel S, Eliassi-Revivo P, Lifshitz D, Friedman E, Korach J.
- Int J Gynaecol Obstet. 2021 Jul 29. doi: 10.1002/ijgo.13843. Epub ahead of print.
- PMID: 34324701
- PubMed abstract
- Source abstract
-
- Bilateral Salpingo-Oophorectomy to Reduce Breast Cancer Risk in Women With Germline BRCA1 or BRCA2 Pathogenic Variants-Caution Needed.
- Conduit C, Milne RL, Phillips KA.
- JAMA Oncol. 2021 Jul 1. doi: 10.1001/jamaoncol.2021.2037. Epub ahead of print.
- PMID: 34196653
- PubMed abstract
- Source abstract
Letter, Reply:
Bilateral Salpingo-Oophorectomy to Reduce Breast Cancer Risk in Women With Germline BRCA1 or BRCA2 Pathogenic Variants-Caution Needed-Reply.
- PMID: 34196652
- PubMed abstract
- Source abstract
Original research:
Association of Risk-Reducing Salpingo-Oophorectomy With Breast Cancer Risk in Women With BRCA1 and BRCA2 Pathogenic Variants.
- PMID: 33630024
- PubMed abstract
- Source abstract
-
- A rectovaginal septum mass in a BRCA1 positive patient years after risk reducing surgery: A case report.
- Blankenship L, Lyons YA, Dao Campi H, Valente PT, Barnes L, Kost ER.
- Gynecol Oncol Rep. 2021 May 5;36:100772. doi: 10.1016/j.gore.2021.100772.
- PMID: 34026998
- PubMed abstract
- Case report
- Free PMC article
- Free Full Text
-
- Hormone replacement therapy in BRCA mutation carriers and risk of ovarian, endometrial, and breast cancer: a systematic review.
- Huber D, Seitz S, Kast K, Emons G, Ortmann O.
- J Cancer Res Clin Oncol. 2021 Apr 22. doi: 10.1007/s00432-021-03629-z. Epub ahead of print.
- PMID: 33885953
- PubMed abstract
- Review
- Free Full Text
-
- Association of Risk-Reducing Salpingo-Oophorectomy With Breast Cancer Risk in Women With BRCA1 and BRCA2 Pathogenic Variants.
- Choi YH, Terry MB, Daly MB, MacInnis RJ, Hopper JL, Colonna S, Buys SS, Andrulis IL, John EM, Kurian AW, Briollais L.
- JAMA Oncol. 2021 Apr 1;7(4):585-592. doi: 10.1001/jamaoncol.2020.7995.
- PMID: 33630024
- PubMed abstract
- Source abstract
Letter, Comment:
Bilateral Salpingo-Oophorectomy to Reduce Breast Cancer Risk in Women With Germline BRCA1 or BRCA2 Pathogenic Variants-Caution Needed.
- PMID: 34196653
- PubMed abstract
- Source abstract
Letter, Reply:
Bilateral Salpingo-Oophorectomy to Reduce Breast Cancer Risk in Women With Germline BRCA1 or BRCA2 Pathogenic Variants-Caution Needed-Reply.
- PMID: 34196652
- PubMed abstract
- Source abstract
-
- Risk-reducing hysterectomy and bilateral salpingo-oophorectomy in female heterozygotes of pathogenic mismatch repair variants: a Prospective Lynch Syndrome Database report.
- Dominguez-Valentin M, Crosbie EJ, Engel C, Aretz S, Macrae F, Winship I, Capella G, Thomas H, Nakken S, Hovig E, Nielsen M, Sijmons RH, Bertario L, Bonanni B, Tibiletti MG, Cavestro GM, Mints M, Gluck N, Katz L, Heinimann K, Vaccaro CA, Green K, Lalloo F, Hill J, Schmiegel W, Vangala D, Perne C, Strauß HG, Tecklenburg J, Holinski-Feder E, Steinke-Lange V, Mecklin JP, Plazzer JP, Pineda M, Navarro M, Vidal JB, Kariv R, Rosner G, Piñero TA, Gonzalez ML, Kalfayan P, Ryan N, Ten Broeke SW, Jenkins MA, Sunde L, Bernstein I, Burn J, Greenblatt M, de Vos Tot Nederveen Cappel WH, Della Valle A, Lopez-Koestner F, Alvarez K, Büttner R, Görgens H, Morak M, Holzapfel S, Hüneburg R, von Knebel Doeberitz M, Loeffler M, Rahner N, Weitz J, Pylvänäinen K, Renkonen-Sinisalo L, Lepistö A, Auranen A, Hopper JL, Win AK, Haile RW, Lindor NM, Gallinger S, Le Marchand L, Newcomb PA, Figueiredo JC, Thibodeau SN, Therkildsen C, Okkels H, Ketabi Z, Denton OG, Rødland EA, Vasen H, Neffa F, Esperon P, Tjandra D, Möslein G, Sampson JR, Evans DG, Seppälä TT, Møller P.
- Genet Med. 2021 Apr;23(4):705-712. doi: 10.1038/s41436-020-01029-1. Epub 2020 Dec 1.
- PMID: 33257847
- PubMed abstract
-
- Breast cancer risk and hormone replacement therapy among BRCA carriers after risk-reducing salpingo-oophorectomy.
- Michaelson-Cohen R, Gabizon-Peretz S, Armon S, Srebnik-Moshe N, Mor P, Tomer A, Levy-Lahad E, Paluch-Shimon S.
- Eur J Cancer. 2021 Mar 16;148:95-102. doi: 10.1016/j.ejca.2021.02.007. Epub ahead of print.
- PMID: 33743487
- PubMed abstract
- Source abstract
-
- Specialist oncological surgery for removal of the ovaries and fallopian tubes in BRCA1 and BRCA2 pathogenic variant carriers may reduce primary peritoneal cancer risk to very low levels.
- Crosbie EJ, Flaum N, Harkness EF, Clayton RD, Holland C, Martin-Hirsch P, Wood N, Keating P, Woodward ER, Lalloo F, Donnai P, Edmondson RJ, Evans DG.
- Int J Cancer. 2021 Mar 1;148(5):1155-1163. doi: 10.1002/ijc.33378. Epub 2020 Nov 11.
- PMID: 33152107
- PubMed abstract
- Source abstract
-
- Survival from breast cancer in women with a BRCA2 mutation by treatment.
- Evans DG, Phillips KA, Milne RL, Fruscio R, Cybulski C, Gronwald J, Lubinski J, Huzarski T, Hyder Z, Forde C, Metcalfe K, Senter L, Weitzel J, Tung N, Zakalik D, Ekholm M, Sun P, Narod SA; kConFab Investigators, Polish Hereditary Breast Cancer Consortium, Hereditary Breast Cancer Clinical Study Group.
- Br J Cancer. 2021 Feb 18. doi: 10.1038/s41416-020-01164-1. Epub ahead of print.
- PMID: 33597716
- PubMed abstract
- Source abstract
-
- Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
- Daly MB, Pal T, Berry MP, Buys SS, Dickson P, Domchek SM, Elkhanany A, Friedman S, Goggins M, Hutton ML; CGC, Karlan BY, Khan S, Klein C, Kohlmann W; CGC, Kurian AW, Laronga C, Litton JK, Mak JS; LCGC, Menendez CS, Merajver SD, Norquist BS, Offit K, Pederson HJ, Reiser G; CGC, Senter-Jamieson L; CGC, Shannon KM, Shatsky R, Visvanathan K, Weitzel JN, Wick MJ, Wisinski KB, Yurgelun MB, Darlow SD, Dwyer MA.
- J Natl Compr Canc Netw. 2021 Jan 6;19(1):77-102. doi: 10.6004/jnccn.2021.0001.
- PMID: 33406487
- PubMed abstract
- Source abstract
- Guidelines
- Free Full Text
-
- In Response to "Pregnancy After Breast Cancer in Patients With Germline BRCA Mutations".
- Narod SA, Giannakeas V.
- J Clin Oncol. 2020 Dec 20;38(36):4352. doi: 10.1200/JCO.20.02253. Epub 2020 Oct 30.
- PMID: 33125308
- PubMed abstract
- Letter, Commentary
- Free Full Text
Letter, Comment:
Reply to S. A. Narod et al.
- PMID: 33125310
- PubMed abstract
- Free Full Text
Original research:
Pregnancy After Breast Cancer in Patients With Germline BRCA Mutations.
- PMID: 32673153
- PubMed abstract
- Source abstract
-
- Association between BRCA mutations and endometrial carcinoma: a systematic review with meta-analysis.
- Lu G, Lu T, Pan J, Guo L, Pang Y, Liu P.
- Arch Gynecol Obstet. 2020 Nov 20. doi: 10.1007/s00404-020-05887-7.
- PMID: 33215232
- PubMed abstract
- Source abstract
-
- Assessing Effectiveness of Colonic and Gynecological Risk Reducing Surgery in Lynch Syndrome Individuals.
- Dueñas N, Navarro M, Teulé À, Solanes A, Salinas M, Iglesias S, Munté E, Ponce J, Guardiola J, Kreisler E, Carballas E, Cuadrado M, Matias-Guiu X, de la Ossa N, Lop J, Lázaro C, Capellá G, Pineda M, Brunet J.
- Cancers (Basel). 2020 Nov 18;12(11):3419. doi: 10.3390/cancers12113419.
- PMID: 33218006
- PubMed abstract
- Source abstract
-
- Retrospective evaluation of risk-reducing salpingo-oophorectomy for BRCA1/2 pathogenic variant carriers among a cohort study in a single institution.
- Kobayashi Y, Hirasawa A, Chiyoda T, Ueki A, Masuda K, Misu K, Kawaida M, Hayashi S, Kataoka F, Banno K, Kosaki K, Aoki D.
- Jpn J Clin Oncol. 2020 Oct 10:hyaa173. doi: 10.1093/jjco/hyaa173. Epub ahead of print.
- PMID: 33037428
- PubMed abstract
- Source abstract
-
- Morphological and molecular heterogeneity of epithelial ovarian cancer: Therapeutic implications.
- Romero I, Leskelä S, Mies BP, Velasco AP, Palacios J.
- EJC Suppl. 2020 Aug 22;15:1-15. doi: 10.1016/j.ejcsup.2020.02.001.
- PMID: 33240438
- PubMed abstract
- Review
- Free PMC article
- Free Full Text
-
- Penetrance of Breast and Ovarian Cancer in Women Who Carry a BRCA1/2 Mutation and Do Not Use Risk-Reducing Salpingo-Oophorectomy: An Updated Meta-Analysis.
- Chen J, Bae E, Zhang L, Hughes K, Parmigiani G, Braun D, Rebbeck TR.
- JNCI Cancer Spectr. 2020 Apr 23 [eCollection 2020 Aug.];4(4):pkaa029. doi: 10.1093/jncics/pkaa029.
- PMID: 32676552
- PubMed abstract
-
- Hormone therapy after risk-reducing surgery in patients with BRCA1/BRCA2 mutation: evaluation of potential benefits and safety.
- Silva Filho ALD, Carvalho GM, Sena LC, Gomes LPG, Valério MFH, Martins RIL, Cândido EB.
- Rev Assoc Med Bras (1992). 2020 Aug;66(8):1134-1138. doi: 10.1590/1806-9282.66.8.1134.
- PMID: 32935810
- PubMed abstract
- Source abstract
- Review
- Free Full Text
-
- Ovarian Cancer After Prophylactic Salpingectomy in a Patient With Germline BRCA1 Mutation.
- Lugo Santiago N, Smith E, Cox M, Wan CS, Tchabo NE, Awowole I, Broach V, Chi DS.
- Obstet Gynecol. 2020 Jun;135(6):1270-1274. doi: 10.1097/AOG.0000000000003864.
- PMID: 32459417
- PubMed abstract
- Source abstract
Editorial:
Too Good to Be True.
- PMID: 32459416
- PubMed abstract
- Source abstract
-
- Association of premenopausal risk-reducing salpingo-oophorectomy with breast cancer risk in BRCA1/2 mutation carriers: Maximising bias-reduction.
- Stjepanovic N, Villacampa G, Nead KT, Torres-Esquius S, Melis GG, Nathanson KL, Teule A, Brunet J, Y Cajal TR, Llort G, Dienstmann R, Rue M, Domchek SM, Balmaña J.
- Eur J Cancer. 2020 Apr 20;132:53-60. doi: 10.1016/j.ejca.2020.03.009. [Epub ahead of print]
- PMID: 32325420
- PubMed abstract
- Source abstract
-
- Is hormonal therapy after risk-reducing salpingo-oophorectomy associated with an increased risk of malignancy in pathogenic variant carriers?
- Mills KA, Joshi TV, West L, Kuznicki M, Kent L, Hokenstad AN, Cripe JC, Woolfolk C, Senter L, Bakkum-Gamez JN, Wenham RM, Cohn DE, Bae-Jump V, Thaker PH.
- Gynecol Oncol. 2020 Mar 3. pii: S0090-8258(20)30179-7. doi: 10.1016/j.ygyno.2020.02.033. [Epub ahead of print]
- PMID: 32143914
- PubMed abstract
- Source abstract
-
- Occult Tubal Carcinoma After Risk-Reducing Salpingo-oophorectomy: A Systematic Review.
- Piedimonte S, Frank C, Laprise C, Quaiattini A, Gotlieb WH.
- Obstet Gynecol. 2020 Mar;135(3):498-508. doi: 10.1097/AOG.0000000000003702.
- PMID: 32028491
- PubMed abstract
- Source abstract
Editorial:
Unanswered Questions in High-Risk Women Undergoing Risk-Reducing Salpingo-oophorectomy.
- PMID: 32028509
- PubMed abstract
- Source abstract
Press: Cancer Threat Persists After Risk-Reducing Surgery — Occult tumors, recurrence, new cancers after prophylactic salpingo-oophorectomy. (Medpage Today)
-
- Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers.
- Mavaddat N, Antoniou AC, Mooij TM, Hooning MJ, Heemskerk-Gerritsen BA; GENEPSO, Noguès C, Gauthier-Villars M, Caron O, Gesta P, Pujol P, Lortholary A; EMBRACE, Barrowdale D, Frost D, Evans DG, Izatt L, Adlard J, Eeles R, Brewer C, Tischkowitz M, Henderson A, Cook J, Eccles D; HEBON, van Engelen K, Mourits MJE, Ausems MGEM, Koppert LB, Hopper JL, John EM, Chung WK, Andrulis IL, Daly MB, Buys SS; kConFab Investigators, Benitez J, Caldes T, Jakubowska A, Simard J, Singer CF, Tan Y, Olah E, Navratilova M, Foretova L, Gerdes AM, Roos-Blom MJ, Van Leeuwen FE, Arver B, Olsson H, Schmutzler RK, Engel C, Kast K, Phillips KA, Terry MB, Milne RL, Goldgar DE, Rookus MA, Andrieu N, Easton DF; IBCCS; kConFab; BCFR.
- Breast Cancer Res. 2020 Jan 16;22(1):8. doi: 10.1186/s13058-020-1247-4.
- PMID: 31948486
- PubMed abstract
-
- Increased Overall Mortality Even after Risk Reducing Surgery for BRCA-Positive Women in Western Sweden.
- Öfverholm A, Einbeigi Z, Wigermo A, Holmberg E, Karsson P.
- Genes (Basel). 2019 Dec 16;10(12). pii: E1046. doi: 10.3390/genes10121046.
- PMID: 31888263
- PubMed abstract
- Source abstract
-
- Peritoneal cancer after bilateral mastectomy, hysterectomy, and bilateral salpingo-oophorectomy with a poor prognosis: A case report and review of the literature.
- Ma YN, Bu HL, Jin CJ, Wang X, Zhang YZ, Zhang H.
- World J Clin Cases. 2019 Nov 26;7(22):3872-3880. doi: 10.12998/wjcc.v7.i22.3872.
- PMID: 31799317
- PubMed abstract
- Source abstract
- Case report
- Free PMC article
- Free Full Text
-
- Risk-Reducing Salpingo-Oophorectomy and Breast Cancer Risk Reduction in the Gynecologic Oncology Group Protocol-0199 (GOG-0199).
- Mai PL, Miller A, Gail MH, Skates S, Lu K, Sherman ME, Ioffe OB, Rodriguez G, Cohn DE, Boggess J, Rutherford T, Kauff ND, Rader JS, Phillips KA, DiSilvestro PA, Olawaiye AB, Ridgway MR, Greene MH, Piedmonte M, Walker JL.
- JNCI Cancer Spectr. 2019 Oct 10;4(1):pkz075. doi: 10.1093/jncics/pkz075. eCollection 2020 Feb.
- PMID: 32337492
- PubMed abstract
Commentary:
Preventing Breast Cancer in High-Risk Women: Is There Still a Role for Oophorectomy?
- PMID: 32337493
- PubMed abstract
- Free Full Text
-
- A comparison of ovarian cancer mortality in women with BRCA1 mutations undergoing annual ultrasound screening or preventive oophorectomy.
- Gronwald J, Lubinski J, Huzarski T, Cybulski C, Menkiszak J, Siołek M, Stawicka M, Sun P, Kim S, Kotsopoulos J, Narod SA.
- Gynecol Oncol. 2019 Sep 6. pii: S0090-8258(19)31486-6. doi: 10.1016/j.ygyno.2019.08.034. [Epub ahead of print]
- PMID: 31500890
- PubMed abstract
- Source abstract
-
- Oophorectomy and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers.
- Kotsopoulos J, Lubinski J, Lynch HT, Tung N, Armel S, Senter L, Singer CF, Fruscio R, Couch F, Weitzel JN, Karlan B, Foulkes WD, Moller P, Eisen A, Ainsworth P, Neuhausen SL, Olopade O, Sun P, Gronwald J, Narod SA; Hereditary Breast Cancer Clinical Study Group.
- Breast Cancer Res Treat. 2019 Jun;175(2):443-449. doi: 10.1007/s10549-019-05162-7. Epub 2019 Feb 12.
- PMID: 30756284
- PubMed abstract
- Source abstract
-
- Women's health 2019: Osteoporosis, breast cancer, contraception, and hormone therapy.
- Moreno AC, Sahni SK, Smith TL, Batur P.
- Cleve Clin J Med. 2019 Jun;86(6):400-406. doi: 10.3949/ccjm.86a.18130.
- PMID: 31204979
- PubMed abstract
-
- Development of Peritoneal Carcinoma in women diagnosed with Serous Tubal Intraepithelial Carcinoma (STIC) following Risk-Reducing Salpingo-Oophorectomy (RRSO).
- Stanciu PI, Ind TEJ, Barton DPJ, Butler JB, Vroobel KM, Attygalle AD, Nobbenhuis MAE.
- J Ovarian Res. 2019 May 25;12(1):50. doi: 10.1186/s13048-019-0525-1.
- PMID: 31128592
- PubMed abstract
-
- Opportunistic Salpingectomy at the Time of Urogynecologic Surgery: Why, in Whom, and How?
- Catanzarite T, Eskander RN.
- Female Pelvic Med Reconstr Surg. 2019 May 22. doi: 10.1097/SPV.0000000000000741. [Epub ahead of print]
- PMID: 31135579
- PubMed abstract
- Source abstract
-
- Clinical background and outcomes of risk-reducing salpingo-oophorectomy for hereditary breast and ovarian cancers in Japan.
- Nomura H, Sekine M, Yokoyama S, Arai M, Enomoto T, Takeshima N, Nakamura S.
- Int J Clin Oncol. 2019 May 4. doi: 10.1007/s10147-019-01456-4. [Epub ahead of print]
- PMID: 31055694
- PubMed abstract
- Source abstract
-
- Retrospective study of a 16 year cohort of BRCA1 and BRCA2 carriers presenting for RRSO: Prevalence of invasive and in-situ carcinoma, with follow-up.
- Blok F, Dasgupta S, Dinjens WNM, Roes EM, van Beekhuizen HJ, Ewing-Graham PC.
- Gynecol Oncol. 2019 May;153(2):326-334. doi: 10.1016/j.ygyno.2019.03.003. Epub 2019 Mar 18.
- PMID: 30894273
- PubMed abstract
- Source abstract
-
- Analysis of Outcomes in Patients With BRCA1/2 Breast Cancer Mutations Treated With Accelerated Partial Breast Irradiation (APBI).
- Ahmed F, Christos PJ, Singh P, Parashar B, Wernicke AG.
- Am J Clin Oncol. 2019 Apr 9. doi: 10.1097/COC.0000000000000542. [Epub ahead of print]
- PMID: 30973374
- PubMed abstract
- Source abstract
-
- Selected features of breast and peritoneal cancers diagnosed in BRCA1 carriers after risk-reducing salpingo-oophorectomy.
- Menkiszak J, Chudecka-Głaz A, Cymbaluk-Płoska A, Celewicz A, Kojs Z, Szajda M, Świniarska M, Bedner R, Jurczak A, Celewicz M, Cieszyńska M, Lubiński J, Gronwald J.
- Hered Cancer Clin Pract. 2019 Mar 14;17:10. doi: 10.1186/s13053-019-0109-5. eCollection 2019.
- PMID: 30918533
- PubMed abstract
-
- Risk-Reducing Oophorectomy and Breast Cancer Risk Across the Spectrum of Familial Risk.
- Terry MB, Daly MB, Phillips KA, Ma X, Zeinomar N, Leoce N, Dite GS, MacInnis RJ, Chung WK, Knight JA, Southey MC, Milne RL, Goldgar D, Giles GG, Weideman PC, Glendon G, Buchsbaum R, Andrulis IL, John EM, Buys SS, Hopper JL.
- J Natl Cancer Inst. 2019 Mar 1;111(3):331-334. doi: 10.1093/jnci/djy182.
- PMID: 30496449
- PubMed abstract
Press: Oophorectomy to Reduce Ovarian-cancer Risk Not Tied to Breast-cancer Risk. (Medscape Oncology)
-
- Distinct Histologic, Immunohistochemical and Clinical Features Associated With Serous Endometrial Intraepithelial Carcinoma Involving Polyps.
- Trinh VQ, Pelletier MP, Echelard P, Warkus T, Sauthier P, Gougeon F, Mès-Masson AM, Provencher DM, Rahimi K.
- Int J Gynecol Pathol. 2019 Feb 14. doi: 10.1097/PGP.0000000000000591. [Epub ahead of print]
- PMID: 30789501
- PubMed abstract
- Source abstract
-
- Evaluation of screening and risk-reducing surgery for women followed in a high-risk breast/ovarian cancer clinic: it is all about the tubes in BRCA mutation carriers.
- Stewart ME, Knisely AT, Sullivan MW, Ring KL, Modesitt SC.
- Gynecol Oncol Rep. 2019 Feb 1;28:18-22. doi: 10.1016/j.gore.2019.01.010. eCollection 2019 May.
- PMID: 30775416
- PubMed abstract
- Case report
- Free PMC article
- Free Full Text
-
- Risk Reduction and Survival Benefit of Risk-Reducing Salpingo-oophorectomy in Hereditary Breast Cancer: Meta-analysis and Systematic Review.
- Xiao YL, Wang K, Liu Q, Li J, Zhang X, Li HY.
- Clin Breast Cancer. 2019 Feb;19(1):e48-e65. doi: 10.1016/j.clbc.2018.09.011. Epub 2018 Oct 4.
- PMID: 30470623
- PubMed abstract
- Source abstract
- Review
- Free Full Text
-
- Subsequent breast and high grade serous carcinomas after risk-reducing salpingo-oophorectomy in BRCA mutation carriers and patients with history of breast cancer.
- Straub MM, Podoll MB, David SN, Wiesner GL, Desouki MM.
- Ann Diagn Pathol. 2018 Oct;36:28-30. doi: 10.1016/j.anndiagpath.2018.06.003. Epub 2018 Jun 27.
- PMID: 30055521
- PubMed abstract
- Source abstract
-
- Pathology findings and clinical outcomes after risk reduction salpingo-oophorectomy in BRCA mutation carriers: a multicenter Spanish study.
- Minig L, Cabrera S, Oliver R, Couso A, Rubio MJ, Iacoponi S, Martin-Salamanca MB, Carballo-Rastrilla S, Cádenas-Rebollo JM, García-Garcia A, Gil-Ibáñez B, Juan-Fita MJ, Patrono MG.
- Clin Transl Oncol. 2018 Oct;20(10):1337-1344. doi: 10.1007/s12094-018-1865-9. Epub 2018 Apr 5.
- PMID: 29623583
- PubMed abstract
- Source abstract
-
- Surgical prevention strategies in ovarian cancer.
- Mallen A, Soong TR, Townsend MK, Wenham RM, Crum CP, Tworoger SS.
- Gynecol Oncol. 2018 Oct;151(1):166-175. doi: 10.1016/j.ygyno.2018.08.005. Epub 2018 Aug 4.
- PMID: 30087058
- PubMed abstract
- Source abstract
-
- Hormone therapy and breast cancer risk after ovary removal in women with a BRCA1 mutation.
- [No author given]
- FORCE. XRAYS. 2018 Sep 7.
- Research news
- Free Full Text
Hormone Replacement Therapy After Oophorectomy and Breast Cancer Risk Among BRCA1 Mutation Carriers.
- PMID: 29710224
- PubMed abstract
- Free Full Text
-
- Surgery for BRCA, TP53 and PALB2: a literature review.
- Song CV, Teo SH, Taib NA, Yip CH.
- Ecancermedicalscience. 2018 Aug 29;12:863. doi: 10.3332/ecancer.2018.863. eCollection 2018.
- PMID: 30174725
- PubMed abstract
- Source abstract
- Review
- Free PMC article
- Free Full Text
-
- Risk-reducing bilateral salpingo-oophorectomy in women with BRCA1 or BRCA2 mutations.
- Eleje GU, Eke AC, Ezebialu IU, Ikechebelu JI, Ugwu EO, Okonkwo OO.
- Cochrane Database Syst Rev. 2018 Aug 24;8:CD012464. doi: 10.1002/14651858.CD012464.pub2.
- PMID: 30141832
- PubMed abstract
- Source abstract
-
- Hormone Replacement Therapy After Oophorectomy and Breast Cancer Risk Among BRCA1 Mutation Carriers.
- Kotsopoulos J, Gronwald J, Karlan BY, Huzarski T, Tung N, Moller P, Armel S, Lynch HT, Senter L, Eisen A, Singer CF, Foulkes WD, Jacobson MR, Sun P, Lubinski J, Narod SA; Hereditary Breast Cancer Clinical Study Group.
- JAMA Oncol. 2018 Aug 1;4(8):1059-1065. doi: 10.1001/jamaoncol.2018.0211.
- PMID: 29710224
- PubMed abstract
- Source abstract
Research News: Hormone therapy and breast cancer risk after ovary removal in women with a BRCA1 mutation. (FORCE, XRAYS)
Commentary, Video: Menopausal Hormone Therapy and Risk for Breast Cancer in BRCA1 Mutation Carriers. (Medscape)
-
- Outcome and Prognostic Impact of Surgical Staging in Serous Tubal Intraepithelial Carcinoma: A Cohort Study and Systematic Review.
- Van der Hoeven NMA, Van Wijk K, Bonfrer SE, Beltman JJ, Louwe LA, De Kroon CD, Van Asperen CJ, Gaarenstroom KN.
- Clin Oncol (R Coll Radiol). 2018 Aug;30(8):463-471. doi: 10.1016/j.clon.2018.03.036. Epub 2018 Apr 22.
- PMID: 29691126
- PubMed abstract
- Source abstract
-
- Mortality and Risk of Cancer After Prophylactic Bilateral Oophorectomy in Women With a Family History of Cancer.
- Abildgaard J, Ahlström MG, Daugaard G, Nielsen DL, Tønnes Pedersen A, Lindegaard B, Obel N.
- JNCI Cancer Spectrum. 2018 Jul 1;2(3):pky034. doi: 10.1093/jncics/pky034.
-
- Uptake of risk-reducing surgery in BRCA gene carriers in Wales, UK.
- Long J, Evans TG, Bailey D, Lewis MH, Gower-Thomas K, Murray A.
- Breast J. 2018 Jul;24(4):580-585. doi: 10.1111/tbj.12978. Epub 2017 Dec 29.
- PMID: 29286205
- PubMed abstract
- Source abstract
-
- Does oophorectomy reduce breast cancer mortality for BRCA mutation carriers after breast cancer?
- Jacobson M, Narod SA.
- Expert Rev Anticancer Ther. 2018 Apr;18(4):305-306. doi: 10.1080/14737140.2018.1438891. Epub 2018 Feb 16.
- PMID: 29431530
- PubMed abstract
- Source abstract
- Editorial
- Free Full Text
-
- Genetic and clinical characteristics in Japanese hereditary breast and ovarian cancer: first report after establishment of HBOC registration system in Japan.
- Arai M, Yokoyama S, Watanabe C, Yoshida R, Kita M, Okawa M, Sakurai A, Sekine M, Yotsumoto J, Nomura H, Akama Y, Inuzuka M, Nomizu T, Enomoto T, Nakamura S.
- J Hum Genet. 2018 Apr;63(4):447-457. doi: 10.1038/s10038-017-0355-1. Epub 2017 Nov 8.
- PMID: 29176636
- PubMed abstract
-
- Peritoneal carcinomatosis after risk-reducing surgery in BRCA1/2 mutation carriers.
- Harmsen MG, Piek JMJ, Bulten J, Casey MJ, Rebbeck TR, Mourits MJ, Greene MH, Slangen BFM, van Beurden M, Massuger LFAG, Hoogerbrugge N, de Hullu JA.
- Cancer. 2018 Mar 1;124(5):952-959. doi: 10.1002/cncr.31211. Epub 2018 Jan 9.
- PMID: 29315498
- PubMed abstract
- Source abstract
Editorial:
Who is at risk after risk reduction?
- PMID: 29315505
- PubMed abstract
- Source abstract
-
- Peritoneal cancer arising after total abdominal hysterectomy and bilateral salpingo-oophorectomy for cervical cancer in a patient with right breast cancer and germline mutation of BRCA1 gene: a case report and literature review.
- Harao M, Ando J, Kamata H, Hoshi N, Igarashi S, Sekiguchi R, Sugano K.
- Breast Cancer. 2018 Mar;25(2):243-249. doi: 10.1007/s12282-017-0813-9. Epub 2017 Nov 1.
- PMID: 29094253
- PubMed abstract
- Source abstract
-
- Risk of Serous Endometrial Carcinoma in Women With Pathogenic BRCA1/2 Variant After Risk-Reducing Salpingo-Oophorectomy.
- Saule C, Mouret-Fourme E, Briaux A, Becette V, Rouzier R, Houdayer C, Stoppa-Lyonnet D.
- J Natl Cancer Inst. 2018 Feb 1;110(2). doi: 10.1093/jnci/djx159.
- PMID: 28954295
- PubMed abstract
- Source abstract
-
- Evaluation of Transvaginal Ultrasound plus CA-125 Measurement and Prophylactic Salpingo-Oophorectomy in Women at Different Risk Levels of Ovarian Cancer: The Modena Study Group Cohort Study.
- Cortesi L, De Matteis E, Toss A, Marchi I, Medici V, Contu G, Xholli A, Grandi G, Cagnacci A, Federico M.
- Oncology. [2017 Dec;]93(6):377-386. doi: 10.1159/000479155. Epub 2017 Aug 26.
- PMID: 28848147
- PubMed abstract
- Source abstract
-
- The Role of Routine Peritoneal and Omental Biopsies at Risk-Reducing Salpingo-Oophorectomy.
- Miller H, Pipkin LS, Tung C, Hall TR, Masand RP, Anderson ML.
- J Minim Invasive Gynecol. 2017 Jul - Aug;24(5):772-776. doi: 10.1016/j.jmig.2017.03.001. Epub 2017 Mar 8.
- PMID: 28285055
- PubMed abstract
- Source abstract
-
- No. 344-Opportunistic Salpingectomy and Other Methods of Risk Reduction for Ovarian/Fallopian Tube/Peritoneal Cancer in the General Population.
- Salvador S, Scott S, Francis JA, Agrawal A, Giede C.
- J Obstet Gynaecol Can. 2017 Jun;39(6):480-493. doi: 10.1016/j.jogc.2016.12.005.
- PMID: 28527613
- PubMed abstract
- Source abstract
Practice Guideline, Review, [Article in French]:
No 344-Salpingectomie opportuniste et autres méthodes pour réduire le risque de cancer de l'ovaire, de la trompe de Fallope et du péritoine dans la population générale.
- PMID: 28527614
- PubMed abstract
- Source abstract
-
- No 344-Salpingectomie opportuniste et autres méthodes pour réduire le risque de cancer de l'ovaire, de la trompe de Fallope et du péritoine dans la population générale.
- Salvador S, Scott S, Francis JA, Agrawal A, Giede C.
- J Obstet Gynaecol Can. 2017 Jun;39(6):494-508. doi: 10.1016/j.jogc.2017.03.121.
- PMID: 28527614
- PubMed abstract
- Source abstract
Practice Guideline, Review, English Abstract:
No. 344-Opportunistic Salpingectomy and Other Methods of Risk Reduction for Ovarian/Fallopian Tube/Peritoneal Cancer in the General Population.
- PMID: 28527613
- PubMed abstract
- Source abstract
-
- Risk-reducing salpingectomy: Let us be opportunistic.
- Long Roche KC, Abu-Rustum NR, Nourmoussavi M, Zivanovic O.
- Cancer. 2017 May 15;123(10):1714-1720. doi: 10.1002/cncr.30528. Epub 2017 Mar 23.
- PMID: 28334425
- PubMed abstract
- Source abstract
Editorial:
Opportunistic salpingectomy: What about the role of the ovary in ovarian cancer?
- PMID: 28334415
- PubMed abstract
- Source abstract
-
- The effect of hormone therapy on quality of life and breast cancer risk after risk-reducing salpingo-oophorectomy: a systematic review.
- Siyam T, Ross S, Campbell S, Eurich DT, Yuksel N.
- BMC Womens Health. 2017 Mar 21;17(1):22. doi: 10.1186/s12905-017-0370-6.
- PMID: 28320467
- PubMed abstract
- Review
- Free Full Text
-
- Early-onset primary peritoneal carcinoma from atypical cells after risk-reducing salpingo-oophorectomy for BRCA2 mutation carrier: a case report.
- Shimizu H, Ishikawa T, Iitsuka C, Homma M, Takimoto M, Sekizawa A.
- Int Cancer Conf J. 2017 Mar 21;6(3):104-108. doi: 10.1007/s13691-017-0287-9. eCollection 2017 Jul.
- PMID: 31149481
- PubMed abstract
- Source abstract
- Case report
- Free PMC article
-
- Reservations About Risk-Reducing Salpingo-oophorectomy Without Hysterectomy in Women With BRCA Mutations.
- Narod SA.
- JAMA Oncol. 2017 Mar 1;3(3):417. doi: 10.1001/jamaoncol.2016.3952.
- PMID: 27832244
- PubMed abstract
- Source abstract
Letter, Reply:
Reservations About Risk-Reducing Salpingo-oophorectomy Without Hysterectomy in Women With BRCA Mutations-Reply.
- PMID: 27832251
- PubMed abstract
- Source abstract
Original Investigation:
Uterine Cancer After Risk-Reducing Salpingo-oophorectomy Without Hysterectomy in Women With BRCA Mutations.
- PMID: 27367496
- PubMed abstract
- Source abstract
-
- Uterine Cancer After Risk-Reducing Salpingo-oophorectomy Without Hysterectomy in Women With BRCA Mutations.
- Shu CA, Pike MC, Jotwani AR, Friebel TM, Soslow RA, Levine DA, Nathanson KL, Konner JA, Arnold AG, Bogomolniy F, Dao F, Olvera N, Bancroft EK, Goldfrank DJ, Stadler ZK, Robson ME, Brown CL, Leitao MM Jr, Abu-Rustum NR, Aghajanian CA, Blum JL, Neuhausen SL, Garber JE, Daly MB, Isaacs C, Eeles RA, Ganz PA, Barakat RR, Offit K, Domchek SM, Rebbeck TR, Kauff ND.
- JAMA Oncol. 2016 Nov 1;2(11):1434-1440. doi: 10.1001/jamaoncol.2016.1820.
- PMID: 27367496
- PubMed abstract
- Source abstract
Comments on NSGC Discussion Forum Cancer SIG:
Subject: BRCA1 loss of expression in Uetrine Serous carcinoma
Subject: Register for August webinar, July webinar slides and recording posted
Webinar: Cancer SIG Aug Journal Club: Uterine Cancer After RRSO w/o Hysterectomy in Women with BRCA mutations. (NSGC. Cancer SIG Journal Club.)
Editorial:
Drawing the Line in Risk-Reducing Gynecologic Surgery in Women With a BRCA Mutation.
- PMID: 27367041
- PubMed abstract
- Source abstract
Letter, Comment:
Reservations About Risk-Reducing Salpingo-oophorectomy Without Hysterectomy in Women With BRCA Mutations.
- PMID: 27832244
- PubMed abstract
- Source abstract
Letter, Reply:
Reservations About Risk-Reducing Salpingo-oophorectomy Without Hysterectomy in Women With BRCA Mutations-Reply.
- PMID: 27832251
- PubMed abstract
- Source abstract
News:
BRCA mutations and risk of uterine cancer.
- PMID: 27397041
- PubMed abstract
- Source abstract
Press: Uterine cancer risk higher for women with ‘breast cancer gene’ mutation (Washington Post)
Press: BRCA1 Mutation Increases Uterine Cancer Risk (Medscape/Reuters Health)
-
- STIC-ing with what we know.
- Chen LM.
- Gynecol Oncol. 2016 Nov;143(2):227-228. doi: 10.1016/j.ygyno.2016.10.007.
- PMID: 27772617
- PubMed abstract
- Source abstract
-
- Occult and subsequent cancer incidence following risk-reducing surgery in BRCA mutation carriers.
- Zakhour M, Danovitch Y, Lester J, Rimel BJ, Walsh CS, Li AJ, Karlan BY, Cass I.
- Gynecol Oncol. 2016 Nov;143(2):231-235. doi: 10.1016/j.ygyno.2016.08.336. Epub 2016 Sep 9.
- PMID: 27623252
- PubMed abstract
- Source abstract
-
- Risk reduction and survival benefit of prophylactic surgery in BRCA mutation carriers, a systematic review.
- Ludwig KK, Neuner J, Butler A, Geurts JL, Kong AL.
- Am J Surg. 2016 Oct;212(4):660-669. doi: 10.1016/j.amjsurg.2016.06.010. Epub 2016 Jul 18.
- PMID: 27649974
- PubMed abstract
- Source abstract
-
- Bilateral Oophorectomy and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers.
- Kotsopoulos J, Huzarski T, Gronwald J, Singer CF, Moller P, Lynch HT, Armel S, Karlan B, Foulkes WD, Neuhausen SL, Senter L, Tung N, Weitzel JN, Eisen A, Metcalfe K, Eng C, Pal T, Evans G, Sun P, Lubinski J, Narod SA; Hereditary Breast Cancer Clinical Study Group.
- J Natl Cancer Inst. 2016 Sep 6;109(1). pii: djw177. doi: 10.1093/jnci/djw177. Print 2017 Jan.
- PMID: 27601060
- PubMed abstract
- Source abstract
-
- Cancer SIG Aug Journal Club: Uterine Cancer After RRSO w/o Hysterectomy in Women with BRCA mutations.
- Melanie Baxter
- NSGC. Cancer SIG Journal Club. 2016 Aug 25.
- Webinar
- Slides
- Audio recording
Uterine Cancer After Risk-Reducing Salpingo-oophorectomy Without Hysterectomy in Women With BRCA Mutations.
- PMID: 27367496
- PubMed abstract
- Source abstract
-
- Primary Peritoneal Carcinoma in a BRCA1/2-negative, PALB2-positive patient.
- Kahn R, Garcia-Soto A, Silva-Smith R, Pinto A, George SH.
- Gynecol Oncol Rep. 2016 Aug 2;17:93-5. doi: 10.1016/j.gore.2016.08.001. eCollection 2016.
- PMID: 27547810
- PubMed abstract
- Source abstract
- Case report
- Free PMC article
- Free Full Text
-
- Effectiveness of Prophylactic Surgeries in BRCA1 or BRCA2 Mutation Carriers: A Meta-analysis and Systematic Review.
- Li X, You R, Wang X, Liu C, Xu Z, Zhou J, Yu B, Xu T, Cai H, Zou Q.
- Clin Cancer Res. 2016 Aug 1;22(15):3971-81. doi: 10.1158/1078-0432.CCR-15-1465. Epub 2016 Mar 15.
- PMID: 26979395
- PubMed abstract
- Meta-Analysis, Review
- Free Full Text (PDF)
-
- Primary peritoneal cancer in BRCA carriers after prophylactic bilateral salpingo-oophorectomy.
- Iavazzo C, Gkegkes ID, Vrachnis N.
- J Turk Ger Gynecol Assoc. 2016 Jan 12;17(2):73-6. doi: 10.5152/jtgga.2016.15223. eCollection [2016 Jun;].
- PMID: 27403072
- PubMed abstract
- Source abstract
-
- Prophylactic salpingo-oophorectomy in BRCA1 mutation carriers and postoperative incidence of peritoneal and breast cancers.
- Menkiszak J, Chudecka-Głaz A, Gronwald J, Cymbaluk-Płoska A, Celewicz A, Świniarska M, Wężowska M, Bedner R, Zielińska D, Tarnowska P, Jakubowicz J, Kojs Z.
- J Ovarian Res. 2016 Feb 29;9(1):11. doi: 10.1186/s13048-016-0220-4.
- PMID: 26928677
- PubMed abstract
-
- Risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a 30-year semi-prospective analysis.
- Basu NN, Ingham S, Hodson J, Lalloo F, Bulman M, Howell A, Evans DG.
- Fam Cancer. 2015 Dec;14(4):531-8. doi: 10.1007/s10689-015-9825-9.
- PMID: 26239694
- PubMed abstract
- Source abstract
-
- Clinical outcomes in patients with isolated serous tubal intraepithelial carcinoma (STIC): A comprehensive review.
- Patrono MG, Iniesta MD, Malpica A, Lu KH, Fernandez RO, Salvo G, Ramirez PT.
- Gynecol Oncol. 2015 Dec;139(3):568-572. doi: 10.1016/j.ygyno.2015.09.018. Epub 2015 Sep 25.
- PMID: 26407480
- PubMed abstract
- Source abstract
-
- Breast cancer: oophorectomy for BRCA1 ER--negative disease-an open debate.
- Kauff N, Robson M.
- Nat Rev Clin Oncol. 2015 Sep;12(9):505-6. doi: 10.1038/nrclinonc.2015.130. Epub 2015 Jul 21.
- PMID: 26196251
- PubMed abstract
- Source abstract
-
- Early salpingectomy (TUbectomy) with delayed oophorectomy to improve quality of life as alternative for risk-reducing salpingo-oophorectomy in BRCA1/2 mutation carriers (TUBA study): a prospective non-randomised multicentre study.
- Harmsen MG, Arts-de Jong M, Hoogerbrugge N, Maas AH, Prins JB, Bulten J, Teerenstra S, Adang EM, Piek JM, van Doorn HC, van Beurden M, Mourits MJ, Zweemer RP, Gaarenstroom KN, Slangen BF, Vos MC, van Lonkhuijzen LR, Massuger LF, Hermens RP, de Hullu JA.
- BMC Cancer. 2015 Aug 19;15(1):593. doi: 10.1186/s12885-015-1597-y.
- PMID: 26286255
- PubMed abstract
-
- RE: Breast Cancer Risk After Salpingo-Oophorectomy in Healthy BRCA1/2 Mutation Carriers: Revisiting the Evidence for Risk Reduction.
- Chai X, Domchek S, Kauff N, Rebbeck T, Chen J.
- J Natl Cancer Inst. 2015 Aug 11;107(9). pii: djv217. doi: 10.1093/jnci/djv217. Print 2015 Sep.
- PMID: 26264690
- PubMed abstract
- Source abstract
Breast Cancer Risk After Salpingo-Oophorectomy in Healthy BRCA1/2 Mutation Carriers: Revisiting the Evidence for Risk Reduction.
- PMID: 25788320
- PubMed abstract
- Free article
Letter
Response.
- PMID: 26264691
- PubMed abstract
- Source abstract
-
- Opportunistic salpingectomies for the prevention of a high-grade serous carcinoma: a statement by the Kommission Ovar of the AGO.
- Pölcher M, Hauptmann S, Fotopoulou C, Schmalfeldt B, Meinhold-Heerlein I, Mustea A, Runnebaum I, Sehouli J.
- Arch Gynecol Obstet. 2015 Jul;292(1):231-4. doi: 10.1007/s00404-015-3697-y. Epub 2015 Apr 26.
- PMID: 25914073
- PubMed abstract
- Source abstract
-
- Effect of Oophorectomy on Survival After Breast Cancer in BRCA1 and BRCA2 Mutation Carriers.
- Metcalfe K, Lynch HT, Foulkes WD, Tung N, Kim-Sing C, Olopade OI, Eisen A, Rosen B, Snyder C, Gershman S, Sun P, Narod SA.
- JAMA Oncol. 2015 Jun 1;1(3):306-313. doi: 10.1001/jamaoncol.2015.0658.
- PMID: 26181175
- PubMed abstract
Comment / Editorial
Adjuvant Oophorectomy in the Treatment of Early-Stage BRCA Mutation-Positive Breast Cancer.
- PMID: 26181176
- PubMed abstract
- Free article
Research News
Ovary removal is linked to lower breast cancer mortality in BRCA1 carriers.
- PMID: 25911348
- PubMed abstract
- Source abstract
-
- Adjuvant Oophorectomy in the Treatment of Early-Stage BRCA Mutation-Positive Breast Cancer.
- Disis ML.
- JAMA Oncol. 2015 Jun 1;1(3):313. doi: 10.1001/jamaoncol.2015.0708.
- PMID: 26181176
- PubMed abstract
- Editorial / Commentary
- Free Full Text
-
- Breast Cancer Risk After Salpingo-Oophorectomy in Healthy BRCA1/2 Mutation Carriers: Revisiting the Evidence for Risk Reduction.
- Heemskerk-Gerritsen BA, Seynaeve C, van Asperen CJ, Ausems MG, Collée JM, van Doorn HC, Gomez Garcia EB, Kets CM, van Leeuwen FE, Meijers-Heijboer HE, Mourits MJ, van Os TA, Vasen HF, Verhoef S, Rookus MA, Hooning MJ; Hereditary Breast and Ovarian Cancer Research Group Netherlands.
- J Natl Cancer Inst. 2015 Mar 18;107(5). pii: djv033. doi: 10.1093/jnci/djv033. Print 2015 May.
- PMID: 25788320
- PubMed abstract
- Source abstract
Comments on NSGC Discussion Forum Cancer SIG
Subject: So this is causing a hubbub... rrBSO does not reduce BC risk?
Subject: Register now for the April Journal Club Webinar!
Comment / Letter
RE: Breast Cancer Risk After Salpingo-Oophorectomy in Healthy BRCA1/2 Mutation Carriers: Revisiting the Evidence for Risk Reduction.
- PMID: 26264690
- PubMed abstract
- Source abstract
Reply / Letter
Response.
- PMID: 26264691
- PubMed abstract
- Source abstract
-
- Breast MRI Fibroglandular Volume and Parenchymal Enhancement in BRCA1 and BRCA2 Mutation Carriers Before and Immediately After Risk-Reducing Salpingo-Oophorectomy.
- DeLeo MJ 3rd, Domchek SM, Kontos D, Conant E, Chen J, Weinstein S.
- AJR Am J Roentgenol. 2015 Mar;204(3):669-73. doi: 10.2214/AJR.13.12146.
- PMID: 25714301
- PubMed abstract
- Source abstract
-
- Endometrial adenocarcinoma after risk reducing bilateral salpingo-oophorectomy
- Catherine Naber, Elise Everett, Cheung Wong
- Gynecologic Oncology, 2015 Feb;136(2):395. 2014 NEAGO Abstracts. doi: 10.1016/j.ygyno.2014.11.024.
-
- Salpingectomy as a potential ovarian cancer risk-reducing procedure.
- Poole EM, Rice MS, Crum CP, Tworoger SS.
- J Natl Cancer Inst. 2015 Jan 27 [2015 Feb;];107(2). pii: dju490. doi: 10.1093/jnci/dju490. Print 2015 Feb.
- PMID: 25628373
- PubMed abstract
- Source abstract
- Editorial / Commentary
- Free Full Text
Ovarian cancer risk after salpingectomy: a nationwide population-based study.
- PMID: 25628372
- PubMed abstract
- Free full text
-
- Risk-reducing salpingo-oophorectomy: a meta-analysis on impact on ovarian cancer risk and all cause mortality in BRCA 1 and BRCA 2 mutation carriers.
- Marchetti C, De Felice F, Palaia I, Perniola G, Musella A, Musio D, Muzii L, Tombolini V, Panici PB.
- BMC Womens Health. 2014 Dec 12;14:150. doi: 10.1186/s12905-014-0150-5.
- PMID: 25494812
- PubMed abstract
- Meta-Analysis
- Free PMC article
- Free Full Text
-
- 5Risk of developing uterine corpus cancer (Ut Ca) following risk-reducing salpingo-oophorectomy (RRSO) in women with BRCA mutations.
- Shu CA, Pike M, Jotwani AR, Soslow RA, Levine DA, Konner J, Aghajanian C, Offit K, Barakat RR, Kauff ND.
- Gynecologic Oncology 2014 Aug;134(2):440. Late Breaking Abstracts from the Society of Gynecologic Oncology's 2014 Annual Meeting on Women's Cancer. doi:10.1016/j.ygyno.2014.07.082.
-
- Impact of Oophorectomy on Cancer Incidence and Mortality in Women With a BRCA1 or BRCA2 Mutation.
- Finch AP, Lubinski J, Møller P, Singer CF, Karlan B, Senter L, Rosen B, Maehle L, Ghadirian P, Cybulski C, Huzarski T, Eisen A, Foulkes WD, Kim-Sing C, Ainsworth P, Tung N, Lynch HT, Neuhausen S, Metcalfe KA, Thompson I, Murphy J, Sun P, Narod SA.
- J Clin Oncol. 2014 May 20;32(15):1547-53. doi: 10.1200/JCO.2013.53.2820. Epub 2014 Feb 24.
- PMID: 24567435
- PubMed abstract
- Source abstract
Comment, Editorial:
A major step forward for BRCA1/2-related cancer risk management.
- PMID: 24687832
- PubMed abstract
- Free Full Text
Research news: Oophorectomy in women with BRCA1 or BRCA2 mutations. (Lancet Oncology)
Press: Early Surgery in BRCA1 Carriers Lowers Ovarian Cancer Risk. (Medscape)
Press: Young women with BRCA1 mutation 'should remove ovaries earlier'. (Medical News Today)
-
- The impact of risk-reducing hysterectomy and bilateral salpingo-oophorectomy on survival in patients with a history of breast cancer-A population-based data linkage study.
- Obermair A, Youlden DR, Baade PD, Janda M.
- Int J Cancer. 2014 May 1;134(9):2211-22. doi: 10.1002/ijc.28537. Epub 2013 Oct 31.
- PMID: 24127248
- PubMed abstract
- Source abstract
-
- Prophylactic bilateral salpingectomy (PBS) to reduce ovarian cancer risk incorporated in standard premenopausal hysterectomy: complications and re-operation rate.
- Vorwergk J, Radosa MP, Nicolaus K, Baus N, Jimenez Cruz J, Rengsberger M, Gajda M, Diebolder H, Runnebaum IB.
- J Cancer Res Clin Oncol. 2014 May;140(5):859-65. doi: 10.1007/s00432-014-1622-6. Epub 2014 Feb 27.
- PMID: 24573653
- PubMed abstract
- Source abstract
-
- Lower mitotic activity in BRCA1/2-associated primary breast cancers occurring after risk-reducing salpingo-oophorectomy.
- van Verschuer VM, Heemskerk-Gerritsen BA, van Deurzen CH, Obdeijn IM, Tilanus-Linthorst MM, Verhoef C, Schmidt MK, Koppert LB, Hooning MJ, Seynaeve C.
- Cancer Biol Ther. 2014 Apr;15(4):371-9. doi: 10.4161/cbt.27628. Epub 2014 Jan 14.
- PMID: 24423863
- PubMed abstract
- Source abstract
-
- BRCA1 Linked to Higher Risk for Aggressive Uterine Cancer.
- Roxanne Nelson.
- Medscape Medical News from the Society of Gynecologic Oncology (SGO) 45th Annual Meeting on Women's Cancer, 2014 Mar 25.
- Press article
- Free Full Text
-
- Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: A Systematic Review to Update the U.S. Preventive Services Task Force Recommendation.
- Nelson HD, Pappas M, Zakher B, Mitchell JP, Okinaka-Hu L, Fu R.
- Ann Intern Med. 2014 Feb 18;160(4):255-66.
- PMID: 24366442
- PubMed abstract
- Review
- Free Full Text
Quality-assessed Review: Database of Abstracts of Reviews of Effects (DARE) (PubMed Health)
-
- Assessing the Genetic Risk for BRCA-Related Breast or Ovarian Cancer in Women: Recommendations From the U.S. Preventive Services Task Force.
- [No authors listed]
- Ann Intern Med. 2014 Feb 18;160(4). doi: 10.7326/P14-9008.
- PMID: 24366402
- PubMed abstract
- Summary for Patients
- Free Full Text
Systematic Review:
Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: A Systematic Review to Update the U.S. Preventive Services Task Force Recommendation.
- PMID: 24366442
- PubMed abstract
-
- Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: U.S. Preventive Services Task Force Recommendation Statement.
- Moyer VA; U.S. Preventive Services Task Force.
- Ann Intern Med. 2014 Feb 18;160(4):271-81.
- PMID: 24366376
- PubMed abstract
- Practice Guideline
- Free Full Text
Patient Education Handout:
Summaries for patients. Assessing the genetic risk for BRCA-related breast or ovarian cancer in women: recommendations from the U.S. Preventive Services Task Force.
- PMID: 25006622
- PubMed abstract
-
- Summaries for patients. Assessing the genetic risk for BRCA-related breast or ovarian cancer in women: recommendations from the U.S. Preventive Services Task Force.
- [No authors listed]
- Ann Intern Med. 2014 Feb 18;160(4):I-16.
- PMID: 25006622
- PubMed abstract
- Summary for Patients
- Free Full Text
Practice Guideline:
Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: U.S. Preventive Services Task Force Recommendation Statement.
- PMID: 24366376
- PubMed abstract
-
- Outcome of unexpected adnexal neoplasia discovered during risk reduction salpingo-oophorectomy in women with germ-line BRCA1 or BRCA2 mutations.
- Conner JR, Meserve E, Pizer E, Garber J, Roh M, Urban N, Drescher C, Quade BJ, Muto M, Howitt BE, Pearlman MD, Berkowitz RS, Horowitz N, Crum CP, Feltmate C.
- Gynecol Oncol. 2014 Feb;132(2):280-6. doi: 10.1016/j.ygyno.2013.12.009. Epub 2013 Dec 12.
- PMID: 24333842
- PubMed abstract
- Source abstract
Comment/Editorial:
Risk reducing salpingo-oophorectomy for BRCA mutation carriers: twenty years later.
- PMID: 24528542
- PubMed abstract
- Source abstract
-
- Clinical Outcome of Isolated Serous Tubal Intraepithelial Carcinomas (STIC).
- Wethington SL, Park KJ, Soslow RA, Kauff ND, Brown CL, Dao F, Otegbeye E, Sonoda Y, Abu-Rustum NR, Barakat RR, Levine DA, Gardner GJ.
- Int J Gynecol Cancer. 2013 Nov;23(9):1603-11. doi: 10.1097/IGC.0b013e3182a80ac8.
- PMID: 24172097
- PubMed abstract
-
- [Characteristics of selected clinical features in BRCA1 mutation carriers affected with breast cancer undergoing preventive female genital tract surgeries].
- Menkiszak J, Chudecka-Głaz A, Gronwald J, Bedner R, Cymbaluk-Płoska A, Wezowska M, Zielińska D, Rzepka-Górska I.
- Ginekol Pol. 2013 Sep;84(9):758-64.
- PMID: 24191513
- PubMed abstract
- Source abstract
- [Article in Polish]
- Free Full Text
-
- Endometrium is not the primary site of origin of pelvic high-grade serous carcinoma in BRCA1 or BRCA2 mutation carriers.
- Reitsma W, Mourits MJ, de Bock GH, Hollema H.
- Mod Pathol. 2013 Apr;26(4):572-8. doi: 10.1038/modpathol.2012.169. Epub 2012 Oct 19.
- PMID: 23080033
- PubMed abstract
- Source abstract
-
- Risk-Reducing Appendectomy and the Elimination of BRCA1 -Associated Intraperitoneal Cancer.
- Sitzmann JV, Wiebke EA.
- JAMA Surg. 2013 Mar 1;148(3):285-91. doi: 10.1001/jamasurg.2013.1006.
- PMID: 23552812
- PubMed abstract
- Case report, Meta-Analysis, Review
- Free Full Text
Commentary: The Appendix A Culprit for BRCA1 -Associated Intraperitoneal Cancer? Comment on “Risk-Reducing Appendectomy and the Elimination of BRCA1 -Associated Intraperitoneal Cancer” (JAMA Surgery)
-
- High-Grade Serous Tumor Arising from Fallopian Tube in a BRCA Mutation Carrier after Prophylactic Oophorectomy.
- Lorusso D, Di Rocco R, Mancini M, Raspagliesi F.
- Case Rep Oncol. 2013 Jan;6(1):21-4. doi: 10.1159/000346339. Epub 2013 Jan 9.
- PMID: 23467066
- PubMed abstract
- Source abstract
-
- Pre-diagnosis oophorectomy, estrogen therapy and mortality in a cohort of women diagnosed with breast cancer.
- Nichols HB, Trentham-Dietz A, Newcomb PA, Egan KM, Titus LJ, Hampton JM, Visvanathan K.
- Breast Cancer Res. 2013;15(5):R99.
- PMID: 24152546
- PubMed abstract
-
- Oophorectomy and breast cancer in BRCA mutation carriers--letter.
- Berrino F.
- Cancer Epidemiol Biomarkers Prev. 2012 Aug;21(8):1389. doi: 10.1158/1055-9965.EPI-12-0603. Epub 2012 Jun 4.
- PMID: 22665575
- PubMed abstract
- Source abstract
- Letter, Comment
- Free PMC article
- Free Full Text (PDF)
Oophorectomy after menopause and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.
- PMID: 22564871
- PubMed abstract
-
- Oophorectomy after menopause and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.
- Kotsopoulos J, Lubinski J, Lynch HT, Kim-Sing C, Neuhausen S, Demsky R, Foulkes WD, Ghadirian P, Tung N, Ainsworth P, Senter L, Karlan B, Eisen A, Eng C, Weitzel J, Gilchrist DM, Blum JL, Zakalik D, Singer C, Fallen T, Ginsburg O, Huzarski T, Sun P, Narod SA.
- Cancer Epidemiol Biomarkers Prev. 2012 Jul;21(7):1089-96. doi: 10.1158/1055-9965.EPI-12-0201. Epub 2012 May 7.
- PMID: 22564871
- PubMed abstract
- Source abstract
Comment, Letter:
Oophorectomy and breast cancer in BRCA mutation carriers--letter.
- PMID: 22665575
- PubMed abstract
- Free Full Text
-
- Effectiveness of risk-reducing salpingo-oophorectomy in preventing ovarian cancer in a high-risk French Canadian population.
- Bacha OM, Gregoire J, Grondin K, Edelweiss MI, Laframboise R, Simard J, Plante M.
- Int J Gynecol Cancer. 2012 Jul;22(6):974-8. doi: 10.1097/IGC.0b013e318257b936.
- PMID: 22740003
- PubMed abstract
-
- Postoophorectomy Estrogen Use and Breast Cancer Risk.
- Nichols HB, Trentham-Dietz A, Newcomb PA, Titus LJ, Egan KM, Hampton JM, Visvanathan K.
- Obstet Gynecol. 2012 Jul;120(1):27-36.
- PMID: 22914389
- PubMed abstract
Comments from NSGC Discussion Forum Cancer SIG
Subject: hormonal birth control with ATM mutations?
Comment:
Post-oophorectomy estrogen use and breast cancer risk.
- PMID: 23437447
- PubMed abstract